AllianzIM U.S. Large Cap Buffer10 Sep ETF SEPT 深 沪
已收盘 11-28 16:00:00 美东时间
34.9097
+0.040
+0.11%
华盛通- 最 高34.9097
- 今 开34.83
- 成交量 5824股
- 最 低 34.83
- 昨 收 34.8698
- 总市值 1920.03万
- 52周最高 34.99
- 市盈率 静 --
- 换手率 1.06%
- 52周最低 25.54
- 委 比 -60.00%
- 总股本 55.00万
- 历史最高 34.99
- 量 比 0.67
- 振 幅 0.23%
- 历史最低 23.42
- 每 手 1
- 风险率 1.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多S&P COTALITY CASE-SHILLER INDEX REPORTS ANNUAL GAIN IN SEPTEMBER 2025
The S&P Cotality Case-Shiller U.S. National Home Price NSA Index posted a 1.3% annual gain for September, down from a 1.4% rise in the previous month. Inflation outpaced home prices for a fo...
11-26 00:09
Vistra Reports Third Quarter 2025 Results, Narrows 2025 Guidance, and Initiates 2026 Guidance
Earnings Release Highlights Third quarter 2025 GAAP Net Income of $652 million and third quarter Ongoing Operations Adjusted EBITDA1 of $1,581 million. Narrowed 2025 Ongoing Operations Adjus...
11-06 20:00
Whirlpool Corporation Announces Third-Quarter Results; Delivers Revenue Growth
Delivered YoY revenue growth as new products gain traction in North America, while navigating the near-term unfavorable effects of tariffs Achieved structural cost take out of 100 basis poin...
10-28 04:05
HUSQVARNA GROUP: INTERIM REPORT JANUARY - SEPTEMBER 2025
STOCKHOLM, Oct. 21, 2025 /PRNewswire/ -- Third quarter 2025 Organic sales growth was flat. Net sales decreased by 5% to SEK 9,204m (9,739). Changes in exchange rates impacted by -5%. Operati...
10-21 13:28
T. ROWE PRICE GROUP REPORTS PRELIMINARY MONTH-END ASSETS UNDER MANAGEMENT FOR SEPTEMBER 2025
BALTIMORE, Oct. 10, 2025 /PRNewswire/ -- T. Rowe Price Group, Inc. (NASDAQ-GS: TROW) announced preliminary September month-end assets under management of $1.77 trillion. Preliminary net outf...
10-10 20:30
ChipMOS REPORTS 10.5% YoY INCREASE IN SEPTEMBER 2025 REVENUE; 3Q25 REVENUE INCREASES 7.1% QoQ
HSINCHU, Oct. 9, 2025/PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange: 8150 and Nasdaq: IMOS), an industry leading provider of outsourc...
10-09 18:00
Flywire Corporation (FLYW) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Sept. 19, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Flywire Corporation ("Flywire" or the "Company") (NASDAQ: FLYW) h...
09-20 03:51
TETRA TECHNOLOGIES, INC. INVESTOR DAY SCHEDULED ON SEPTEMBER 25, 2025, AT THE NEW YORK STOCK EXCHANGE
THE WOODLANDS, Texas, Sept. 17, 2025 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) will be hosting an Investor Day on Thursday, September 25, 2025, at 8:30AM...
09-18 03:52
Septerna to Participate in Upcoming Investor Conferences
Septerna, Inc., a clinical-stage biotech company focused on GPCR drug discovery, announced its participation in two upcoming investor conferences in September: the Cantor Global Healthcare Conference 2025 on September 3, 2025, and the 2025 Wells Fargo Healthcare Conference on September 5, 2025. Live webcasts and replays of the presentations will be available on the company’s website. Septerna specializes in advancing GPCR therapies using its prop...
08-27 12:00
Septerna Announces Dosing of the First Participants in Phase 1 Clinical Trial of SEP-631, an Oral Small Molecule MRGPRX2 Negative Allosteric Modulator for the Treatment of Mast Cell-Driven Diseases
Septerna, Inc. has initiated a Phase 1 clinical trial for SEP-631, a novel oral treatment targeting chronic spontaneous urticaria and mast cell-driven diseases. The trial aims to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SEP-631 in healthy volunteers. As a selective negative allosteric modulator of MRGPRX2, SEP-631 inhibits mast cell activation and degranulation, offering potential relief for millions affected b...
08-21 12:00
